That said, Josie ultimately gets my vote as the better option for women in menopause simply because thats their target audience and who they cater to
placebo preserved 5.5% additional weight loss at 88 weeks Typical taper window / 8 to 16 weeks of stepwise dose reduction before full stop Switching GLP-1s / direct substitution on the same injection day is generally well tolerated per clinical practice guidelines Long-term therapy indication / AACE guidelines classify obesity as a chronic disease requiring ongoing treatment Cardiovascular benefit / SELECT trial showed 20% MACE reduction with semaglutide 2.4 mg over 34.2 months Why stopping a GLP-1 abruptly almost always triggers weight regain Abrupt discontinuation of a GLP-1 receptor agonist removes a pharmacological brake on appetite, gastric emptying, and reward-pathway signaling all at once
If you take a diuretic alongside a GLP-1 medication, monitoring your fluid balance becomes doubly important
NHS availability would require both MHRA approval and a positive NICE technology appraisal
We can talk by email, skype, whatsapp, phone or whatever you feel convenient
Individual study result of primary outcome: overall events of neurodegenerative diseases